Navigation Links
Steady Weight Gain Boosts Late-Life Breast Cancer Risk
Date:4/20/2010

Average-sized woman doubles her odds by adding 30 pounds over 30 years, researchers say

TUESDAY, April 20 (HealthDay News) -- Women who pack on the pounds over their lifetime steadily increase their risk for postmenopausal breast cancer, compared with women who maintain their weight, a new study finds.

Earlier studies have linked excess weight with an increased risk for breast cancer in postmenopausal women, but this is one of the few studies that traces the risk as a function of weight gain over time.

"Among women who had never used postmenopausal hormone therapy, those who had a body-mass index (BMI) gain between age 20 and 50 had a doubling of breast cancer risk," said lead researcher Laura Sue, a cancer research fellow at the U.S. National Cancer Institute.

Sue was expected to present the findings Tuesday at the American Association for Cancer Research's annual meeting, in Washington D.C.

For the study, Sue's team collected data on more than 72,000 women who took part in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. When the study began, the women were between 55 and 74 years old. Among these women, 3,677 had developed a postmenopausal breast cancer.

The researchers looked only at women who had had breast cancer and had never taken hormone replacement therapy to reduce menopausal symptoms. Hormone therapy can boost the risk for developing breast cancer, so by looking at women who had never taken the therapy, the researchers were able to better isolate weight as an individual risk factor.

Compared with women who maintained about the same weight at 50 as they had at age 20, women who gained about 30 pounds over the years increased their risk for breast cancer twofold, the study found.

Among the women in the study, almost 57 percent had increased their BMI by five kilograms per meter squared (kg/m2) over 30 years. That's akin to a women 5 feet 4 inches tall putting on about 30 pounds, Sue said.

An increase in BMI of 5 kg/m2 or more over 30 years increased the risk of developing postmenopausal breast cancer by 88 percent, compared with women whose BMI remained stable over the same period.

Among women whose BMI increased 5 kg/m2 or more from the age of 50 onwards, their risk for breast cancer increased 56 percent, compared with women whose BMI remained the same. That means that jumps in weight before and after age 50 boost a woman's odds for postmenopausal breast cancer, the researchers noted.

The increased risk for breast cancer was tied to the weight gain itself, not to becoming obese, Sue added.

The rise in risk may be due to an increase in the production of estrogen in the body's excess fat cells, which in turn may increase the number of cells produced in the breasts, upping the risk for cancer, Sue said.

The bottom line: "We believe healthy BMI maintenance throughout adulthood is important in terms of breast cancer risk," she said.

More information

For more information on breast cancer, visit the American Cancer Society.



SOURCES: Laura Sue, M.P.H., cancer research fellow, U.S. National Cancer Institute; April 20, 2010, presentation, American Association for Cancer Research annual meeting, Washington D.C.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New figures on cancer in Europe show a steady decline in mortality but big variations
2. Gilbert Hospital Forecasts Steady 2010
3. Duffy & Duffy Continues Steady Growth with Addition of Two Seasoned Medical Malpractice Attorneys
4. Weight Watchers Declares Quarterly Dividend
5. Fat-Burning Chemical Points to New Weight-Loss Drug
6. Diabetes Drug Helps Dieting Teens Lose Weight
7. SILS -- A New Houston Weight Loss Surgery -- Single Incision Laparoscopic Surgery
8. Most parents dont realize their 4 or 5 year-olds are overweight or obese
9. Over 70 and Overweight May Add Years to Life
10. A gimmick-free weight-loss pill in the works
11. Pregnant women who are overweight put their infants at risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Antonio, Texas (PRWEB) , ... January 19, 2017 , ... ... the GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 scholarship ... accounts. The competition begins Feb. 1, and the deadline is May 31, with the ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Allegheny Health Network ... patients who seek access to the Network’s programs and services in the greater Pittsburgh ... specialty care appointments will be offered one for that same afternoon. , ...
(Date:1/19/2017)... ... January 19, 2017 , ... For ... serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity ... (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, is ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second consecutive year, ... Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, ... been chosen by their peers for the 2017 list based on their exceptional ...
(Date:1/19/2017)... VA (PRWEB) , ... January 19, 2017 , ... The ... Thrive in 2017, **An FDAnews Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 ... about the 21st Century Cures Act in order to thrive this year? , The ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017  Abaxis, Inc. (NasdaqGS: ABAX ... instruments and consumables for the medical and veterinary markets ... financial results for the third quarter fiscal year 2017, ... 4:15 p.m. ET on Thursday, January 26, 2017.  The ... fiscal year 2017 after the market closes on Thursday, ...
(Date:1/19/2017)... Jan. 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... specializing in the treatment of non-melanoma skin cancers ... superficial radiation therapy, today announced that it will ... financial results on Thursday, February 2, 2017 after the ... a conference call with the investment community on Thursday, ...
(Date:1/19/2017)... , January 19, 2017 Shire ... that the U.S. Food and Drug Administration (FDA) has ... New Drug Application (NDA) for SHP465, a long-acting, triple-bead, ... a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The ... around June 20, 2017, the designated Prescription Drug User ...
Breaking Medicine Technology: